As we advance through 2024, significant updates in Human Immunodeficiency Virus (HIV) and Sexually Transmitted Infections (STI) prevention and treatment are emerging. Recent clinical trials and global research highlight both advances and ongoing challenges in these critical public health areas. How will these developments influence current practices and shape future strategies in HIV and STI management?

In this webinar, our expert speaker will explore these updates, presenting recent epidemiological data on HIV and STIs worldwide to provide a clear picture of current trends. You’ll gain insights into the latest advancements in HIV treatment and prevention, including innovations in long-acting formulations. The session will also cover recent progress in STI treatment and prevention, focusing on emerging strategies such as the use of doxycycline as postexposure prophylaxis.

Learning Objectives:

• Understand recent epidemiology of HIV and STIs globally
• Learn updates on HIV treatment and prevention, including long-acting formulations
• Learn updates on STI treatment and prevention, including doxycycline as postexposure prophylaxis